Total Live Articles: 503

Hypoxic Ischaemic Encephalopathy (HIE)

Hypoxic Ischaemic Encephalopathy (HIE)

Definition

HIE is a specific type of neonatal encephalopathy caused by acute oxygen and blood flow deprivation (hypoxia-ischaemia) that occurred around the time of birth.

Neonatal encephalopathy is a clinical syndrome of disrupted neurologic function in the early neonatal period (first few days of life), in infants born ≥35 weeks of gestation. [Ref]

Causes and Risk Factors

HIE develops following an acute reduction in fetal oxygen delivery and cerebral perfusion, causing hypoxic-ischaemic brain injury, most commonly around the time of labour and delivery [Ref1][Ref2]

Fetal / placental / umbilical factors
  • Umbilical cord prolapse
  • Severe placental abruption
  • Fetal haemorrhage (e.g. vasa praevia)
  • Shoulder dystocia
Maternal / obstetric factors
  • Uterine rupture
  • Amniotic fluid embolism
  • Maternal cardiovascular collapse

Less commonly, postnatal causes: [Ref]

Predisposing antenatal risk factors (that make the fetus more susceptible to hypoxic-ischaemic injury) [Ref1][Ref2]

Clinical Features and Diagnosis

HIE can be diagnosed when BOTH of the following are present: [Ref]

  1. Neonatal encephalopathy
  2. Evidence of acute peripartum hypoxic-ischaemic insult as the cause of neonatal encephalopathy
Diagnostic domain Description / details
Neonatal encephalopathy 3 clinical hallmarks of neonatal encephalopathy: [Ref]
  1. Altered level of consciousness (lethargy / stupor / coma)
  2. Abnormal muscle tone (typically hypotonia)
  3. Abnormal primitive reflexes

EEG can provide objective evidence of encephalopathy [Ref]

Evidence of peripartum hypoxic-ischaemic insult Clinical indicators: [Ref]
  • Presence of a hypoxic-ischaemic insult (see causes and risk factors section above)
  • Fetal heart-rate abnormalities
  • Persistent low Apgar score
  • Need for resuscitation at birth
  • Prolonged and continued need for respiratory support

Objective tests: [Ref]

  • 1st line: blood gas
    • The gas must be taken at birth (umbilical cord sample) or within 60 min of life (early infant blood gas)
    • Supportive findings: severe acidosis (<7-7.1) + ↑ lactate
  • Confirmatory test: MRI showing hypoxic-ischaemic brain injury
    • MRI is also important in excluding possible mimics (e.g. intracranial haemorrhage, structural malformations, stroke)

Complications

HIE remains a major leading cause of infant death

Short-term complications: [Ref]

  • Seizures
  • Dysglycaemia (both hypoglycaemia and hyperglycaemia)
  • Intracranial haemorrhage
  • Systemic multi-organ dysfunction

Long-term complications: [Ref]

  • Cerebral palsy – primary long-term complication
  • Epilepsy – major cause of post-neonatal epilepsy and persistent seizure disorders
  • Cognitive and intellectual problems
  • Speech and communication problems

Management

Mainstay of management involves: [Ref]

Supportive management
  • Stabilise airway, breathing and circulation
  • Correct hypoxaemia, hypotension and hypoglycaemia
  • Maintain normal physiological parameters and avoid further secondary brain injury
  • Manage any clinical or electrographic evidence of seizures
Therapeutic hypothermia Therapeutic hypothermia is the main established neuroprotective treatment for moderate-to-severe HIE:
  • To be started ASAP and within 6 hours of birth
  • Cool to ~33.5°C for 72 hours, followed by gradual rewarming

Rationale: after the initial hypoxic-ischaemic insult, there is a short latent phase, followed by secondary energy failure, seizures, cytotoxic oedema and mitochondrial dysfunction.

Cooling during this early therapeutic window reduces secondary neuronal injury.

There is currently no additional neuroprotective drug routinely recommended to improve outcomes when added to therapeutic hypothermia.

Ongoing assessment and follow-up: [Ref]

  • MRI to assess the pattern and extent of brain injury + provide prognostic information
  • Long-term neurodevelopmental follow-up due to the risk of complications

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

This is a staging environment

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.